Assessing GEO and LEO Repeating Conjunctions Using High Fidelity Brute Force Monte Carlo Simulations

Probability of collision (P(sub c)) estimates for Earth-orbiting satellites typically assume a temporally-isolated conjunction event. However, under certain conditions two objects may experience multiple high-risk close approach events over the course of hours or days. In these repeating conjunction cases, the P(sub c) accumulates as each successive encounter occurs. The NASA Conjunction Assessment Risk Analysis team has updated its brute force Monte Carlo (BFMC) software to estimate such accumulating P(sub c) values for repeating conjunctions. This study describes the updated BFMC algorithm and discusses the implications for conjunction risk assessment

Final design of a space debris removal system

The objective is the removal of medium sized orbital debris in low Earth orbits. The design incorporates a transfer vehicle and a netting vehicle to capture the medium size debris. The system is based near an operational space station located at 28.5 degrees inclination and 400 km altitude. The system uses ground based tracking to determine the location of a satellite breakup or debris cloud. This data is unloaded to the transfer vehicle, and the transfer vehicle proceeds to rendezvous with the debris at a lower altitude parking orbit. Next, the netting vehicle is deployed, tracks the targeted debris, and captures it. After expending the available nets, the netting vehicle returns to the transfer vehicle for a new netting module and continues to capture more debris in the target area. Once all the netting modules are expended, the transfer vehicle returns to the space station's orbit, where it is resupplied with new netting modules from a space shuttle load. The new modules are launched by the shuttle from the ground, and the expended modules are taken back to Earth for removal of the captured debris, refueling, and repacking of the nets. Once the netting modules are refurbished, they are taken back into orbit for reuse. In a typical mission, the system has the ability to capture 50 pieces of orbital debris. One mission will take about six months. The system is designed to allow for a 30 degree inclination change on the outgoing and incoming trips of the transfer vehicle

Assessing Geo and Leo Repeating Conjunctions Using High Fidelity Brute Force Monte Carlo Simulations

Probability of collision (P(sub c)) estimates for Earth-orbiting satellites typically assume a temporally-isolated conjunction event. However, under certain conditions two objects may experience multiple high-risk close approach events over the course of hours or days. In these repeating conjunction cases, the P(sub c) accumulates as each successive encounter occurs. The NASA Conjunction Assessment Risk Analysis team has updated its brute force Monte Carlo (BFMC) software to estimate such accumulating P(sub c) values for repeating conjunctions. This study describes the updated BFMC algorithm and discusses the implications for conjunction risk assessment

Residues of an anthelmintic veterinary drug (closantel) detected in red foxes (Vulpes vulpes) in Scotland

The contamination of the environment by some veterinary medicines and their impact on wild animals is of increasing concern. However, there is a lack of information about their residues in wildlife. The sentinel animals most commonly used for monitoring the level of environmental contamination are birds of prey, and information on other carnivores and scavengers scarce. This study examined the livers from 118 foxes for residues of a range of 18 veterinary medicines (16 anthelmintic agents and 2 metabolites) used on farm livestock. The samples were collected from foxes, primarily in Scotland, shot during legal pest control activities conducted between 2014 and 2019. Closantel residues were detected in 18 samples, and the concentrations found ranged from 6.5 µgkg−1 to 1383 µgkg−1. No other compounds were found in significant quantities. The results show a surprising frequency and level of closantel contamination, raising concerns about both the route of contamination and the potential impacts on wild animals and the environment, such as the potential for significant wildlife contamination to contribute to the development of closantel-resistant parasites. The results also suggest that red fox (Vulpes vulpes) could be a useful sentinel species for detecting and monitoring some veterinary medicine residues in the environment

Joint EUCAR/JRC/CONCAWE Study on: Effects of Gasoline Vapour Pressure and Ethanol Content on Evaporative Emissions from Modern Cars

A test programme designed to investigate the influence of gasoline vapour pressure and ethanol content on evaporative emissions from modern passenger cars has been carried out by the Joint Research Centre of the European Commission jointly with CONCAWE and EUCAR. Seven gasoline passenger cars representative of current EURO 3/4 emissions technology were tested for evaporative emissions with ten different test fuels. The test fuel matrix comprised 60 and 70 kPa hydrocarbon base fuels with 5 and 10% ethanol splash blends and 5 and 10% ethanol matched volatility blends. The evaporative emission tests were carried out according to a test protocol based on the European homologation test procedure, with no additional vehicle conditioning. Although this test protocol turned out to have a considerable influence on the results, the programme has provided valuable information and several clear conclusions can be drawn. The programme confirmed that vapour pressure (DVPE) is a key fuel variable for evaporative emissions. However the effect of vapour pressure is strongly non-linear; the ethanol blends with final DVPE around 75 kPa gave considerably higher evaporative emissions than the lower volatility fuels in most of the vehicles. Differences between fuels with DVPE in the range 60-70 kPa were small. Additional tests on two vehicles performed after the main programme have raised some questions about possible effects of ethanol on carbon canister working capacity and on the role of permeation in determining evaporative emissions.JRC.H.4-Transport and air qualit

Modelling human choices: MADeM and decision‑making

Research supported by FAPESP 2015/50122-0 and DFG-GRTK 1740/2. RP and AR are also part of the Research, Innovation and Dissemination Center for Neuromathematics FAPESP grant (2013/07699-0). RP is supported by a FAPESP scholarship (2013/25667-8). ACR is partially supported by a CNPq fellowship (grant 306251/2014-0)

Effect of angiotensin-converting enzyme inhibitor and angiotensin receptor blocker initiation on organ support-free days in patients hospitalized with COVID-19

IMPORTANCE Overactivation of the renin-angiotensin system (RAS) may contribute to poor clinical outcomes in patients with COVID-19. Objective To determine whether angiotensin-converting enzyme (ACE) inhibitor or angiotensin receptor blocker (ARB) initiation improves outcomes in patients hospitalized for COVID-19. DESIGN, SETTING, AND PARTICIPANTS In an ongoing, adaptive platform randomized clinical trial, 721 critically ill and 58 non–critically ill hospitalized adults were randomized to receive an RAS inhibitor or control between March 16, 2021, and February 25, 2022, at 69 sites in 7 countries (final follow-up on June 1, 2022). INTERVENTIONS Patients were randomized to receive open-label initiation of an ACE inhibitor (n = 257), ARB (n = 248), ARB in combination with DMX-200 (a chemokine receptor-2 inhibitor; n = 10), or no RAS inhibitor (control; n = 264) for up to 10 days. MAIN OUTCOMES AND MEASURES The primary outcome was organ support–free days, a composite of hospital survival and days alive without cardiovascular or respiratory organ support through 21 days. The primary analysis was a bayesian cumulative logistic model. Odds ratios (ORs) greater than 1 represent improved outcomes. RESULTS On February 25, 2022, enrollment was discontinued due to safety concerns. Among 679 critically ill patients with available primary outcome data, the median age was 56 years and 239 participants (35.2%) were women. Median (IQR) organ support–free days among critically ill patients was 10 (–1 to 16) in the ACE inhibitor group (n = 231), 8 (–1 to 17) in the ARB group (n = 217), and 12 (0 to 17) in the control group (n = 231) (median adjusted odds ratios of 0.77 [95% bayesian credible interval, 0.58-1.06] for improvement for ACE inhibitor and 0.76 [95% credible interval, 0.56-1.05] for ARB compared with control). The posterior probabilities that ACE inhibitors and ARBs worsened organ support–free days compared with control were 94.9% and 95.4%, respectively. Hospital survival occurred in 166 of 231 critically ill participants (71.9%) in the ACE inhibitor group, 152 of 217 (70.0%) in the ARB group, and 182 of 231 (78.8%) in the control group (posterior probabilities that ACE inhibitor and ARB worsened hospital survival compared with control were 95.3% and 98.1%, respectively). CONCLUSIONS AND RELEVANCE In this trial, among critically ill adults with COVID-19, initiation of an ACE inhibitor or ARB did not improve, and likely worsened, clinical outcomes. TRIAL REGISTRATION ClinicalTrials.gov Identifier: NCT0273570

Investigation of the distribution of anticoagulant rodenticide residues in red fox (Vulpes vulpes) livers to ensure optimum sampling protocol

The lobular distribution of 9 different anticoagulant rodenticide (AR) residues in the liver of a sentinel predator/scavenger i.e. the red fox (Vulpes vulpes) was determined following multi-residue analysis using Ultra (High) Performance Liquid Chromatography tandem Mass Spectrometry (UHPLC-MS/MS). The aim of the study was to address concerns that if distribution of AR residues in the liver was significantly heterogeneous, analysis of random sub-samples or finite remnants of liver could result in false negatives or lead to incorrect toxicological diagnoses. Intact livers excised from animals shot as part of routine legal pest control activities in Scotland during 2018 and 2019 were sub-sectioned and the lobular concentration of AR residues was investigated. Analysis of individual lobes from 10 different fox livers revealed that AR residues initially detected in a randomly selected small portion of liver tissue were present throughout the liver. Also, in cases where AR residues were not found in the initial randomly selected portion, they were not found in the subsequent more detailed examination. The limit of quantitation was 3 μg kg‐1 and AR residue concentrations ranged from 3 to 885 μg kg−1. Statistical analysis of variance (ANOVA) was performed on the eight and six out of ten livers that tested positive for bromadiolone and brodifacoum, respectively. No statistical evidence was found of differences in mean residue levels of bromadiolone throughout the liver i.e. within and between liver lobes. However, brodifacoum showed a statistically significant difference (p < .001) in mean residue concentration between the lobes but there was no statistical evidence of mean differences within the lobes